Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
about
Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian DrugsGlutamate receptor ion channels: structure, regulation, and functionPharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular diseaseVoltage-Dependent Inhibition of Glycine Receptor Channels by Niflumic AcidAmantadine alleviates postoperative cognitive dysfunction possibly by increasing glial cell line-derived neurotrophic factor in rats.Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.Amantadine: a review of use in child and adolescent psychiatryRecent insights into the mode of action of memantine and ketamineRadiological imaging in ataxia telangiectasia: a review.Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gatingSystematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.Chemically Bonding of Amantadine with Gardenamide A Enhances the Neuroprotective Effects against Corticosterone-Induced Insults in PC12 Cells.Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database.Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptorsMechanistic and structural determinants of NMDA receptor voltage-dependent gating and slow Mg2+ unblock.Does amantadine induce acute psychosis? A case report and literature reviewTarget- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersResting-state functional connectivity of the striatum in early-stage Parkinson's disease: Cognitive decline and motor symptomatology.Amantadine for freezing of gait in patients with Parkinson diseaseAutism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.Ion-dependent gating of kainate receptors.Filled carbon nanotubes in biomedical imaging and drug delivery.Rational drug discovery design approaches for treating Parkinson's disease.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?NMDA receptors: linking physiological output to biophysical operation.Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trial.Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.Actions of bupivacaine, a widely used local anesthetic, on NMDA receptor responses.Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity.Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.Key binding interactions for memantine in the NMDA receptor.Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.Allosteric Inhibitors of NMDA Receptor Functions.Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.
P2860
Q24273361-C03D1B6E-1F28-4958-BCA7-42594C4FF620Q28290774-D3246C5C-78BF-424A-9888-9DCB5DF9901BQ29243373-0C5BB70A-76E5-4708-A732-015661050388Q30355589-3B7DA291-BBAD-4835-B5EE-854306AA85E7Q30370560-90F63D34-2C11-43B4-A5CC-73DAA36160BFQ33770775-DD2022F4-9A44-4D0D-BE88-0DB4A5B1A64CQ34648021-B3BC1D6E-1E96-43E7-9C1B-FC4666F3D454Q35054539-756109B1-2DA5-4320-A3D7-674A329EDBFFQ35135300-AD10C3AC-CDAD-4E7D-BE1B-2A137F2B6A4EQ35514668-83967CDC-9A92-45A8-8C04-1AEA1A81C96BQ36034676-F07D7B22-8ABA-4CDE-8F43-C2285EE7C545Q36184301-6D53367B-95C7-48B0-B91A-7BCA8F8BE5F2Q36188003-6775893D-E0BF-4185-B2C0-50D69E96136BQ36776735-2C8977DF-6600-4070-9F41-4E06B6B9F683Q36777027-4D458431-136C-4BF0-9D57-75B32888E0EBQ36787779-59728C3C-DEB7-4575-AEEC-485D4BB0C4B9Q36799584-B01A8B77-9594-4A6A-8175-9C858E38C34AQ36831708-F008A250-B090-4D1D-953C-F6F5A9DBF302Q36948725-50D08CA3-1037-4601-8207-EA7B6F5BF42CQ37068738-E5A0065C-DC21-4B7F-A746-A6C67708FD43Q37325648-39F598CC-E671-4DF5-9308-E910179A182FQ37559828-44D400E9-F100-469A-80C6-5486CF775F02Q37613298-DAB8457C-CA8D-41CE-BEB1-92D10080C3E2Q38272176-F9AC7308-BEDD-4C45-BAD9-13B9719CE858Q38520864-2F952851-C67A-4C3C-95E7-AF4112E94B69Q38951947-078143FB-FD1B-4610-BD04-6A54CAF97287Q39182931-E04B7242-0480-43B0-AC05-1FCE42A41907Q39346402-4D5DBE08-0444-4797-B5F0-025B8F0356E7Q40170517-74A98EC8-DEDF-4C7B-A7B1-4F399F09F212Q40406487-1B5A4A31-AA2C-4401-BC6B-301A65784D2AQ41546064-02E5BD14-22B5-4AF6-9237-9085731D0DB5Q41981072-D6E24495-B97E-4EFB-88EE-D626EFE4795BQ42252326-014F8026-5525-412A-9A4F-021029686CDCQ42272536-0ECD7DB3-8A04-448C-9C8D-DC4E781A4A1FQ42565522-8654970A-E6E3-4354-BF6E-472C2BCF9A67Q44050418-6F4B1746-BFEE-4F6A-A166-C55EEBE75FBFQ45748694-DD10F3B8-22C8-4E9D-BB22-8F7673FDF5C0Q45807714-295F33D3-79F9-4578-9F8F-68C5F3FEE879Q46543438-601D9B4D-85F1-494D-A83D-5A35D7CEFD15Q46980157-097897D8-21FF-4213-99BB-5AAECA439896
P2860
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@ast
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@en
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@nl
type
label
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@ast
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@en
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@nl
prefLabel
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@ast
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@en
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
@nl
P1476
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block
@en
P2093
Jon W Johnson
Richard J Clarke
P304
P356
10.1523/JNEUROSCI.4262-04.2005
P407
P577
2005-03-01T00:00:00Z